We are live on ! Find out more
ITP

Iron Triangle Partners Portfolio holdings

AUM $875M
1-Year Est. Return 49.85%
This Fund
S&P 500
This Quarter Est. Return
+16.81%
1 Year Est. Return
+49.85%
3 Year Est. Return
+151.9%
5 Year Est. Return
+239.84%
10 Year Est. Return
–
AUM
$773M
AUM Growth
+$88.7M
Cap. Flow
-$11.4M
Cap. Flow %
-1.47%
Top 10 Hldgs %
55.9%
Holding
33
New
10
Increased
7
Reduced
8
Closed
7

Top Buys

Rank Stock Value
1
IDXX icon
Idexx Laboratories
IDXX
+$35.7M
2
SGRY icon
Surgery Partners
SGRY
+$30.3M
3
ILMN icon
Illumina
ILMN
+$26.1M
4
SNY icon
Sanofi
SNY
+$24.4M
5
INSP icon
Inspire Medical Systems
INSP
+$24.3M

Top Sells

Rank Stock Value
1
UTHR icon
United Therapeutics
UTHR
+$47.6M
2
APLS
Apellis Pharmaceuticals
APLS
+$33.5M
3
DXCM icon
DexCom
DXCM
+$28.2M
4
UHS icon
Universal Health Services
UHS
+$24.2M
5
BSX icon
Boston Scientific
BSX
+$21.1M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ESTA icon
26
Establishment Labs
ESTA
$2.71B
$8.58M 1.11%
331,238
-238,888
-42% -$7M
APLS
27
DELISTED
Apellis Pharmaceuticals
APLS
– –
-880,000
Closed -$33.5M
BSX icon
28
Boston Scientific
BSX
$67.6B
– –
-400,000
Closed -$21.1M
EXAS
29
DELISTED
Exact Sciences
EXAS
– –
-250,000
Closed -$17.1M
SWTX
30
DELISTED
SpringWorks Therapeutics
SWTX
– –
-150,211
Closed -$3.47M
UTHR icon
31
United Therapeutics
UTHR
$26.3B
– –
-210,635
Closed -$47.6M
ITCI
32
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-330,549
Closed -$17.2M
OLK
33
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
– –
-738,062
Closed -$10.9M
1
2

Similar funds

8KM
8 Knots Management Dallas, Texas $868M AUM 30.97% 1-Year Est. Return
MFG
MidWestOne Financial Group Iowa City, Iowa $900M AUM 23.95% 1-Year Est. Return
NP
Ninepoint Partners Toronto, Ontario, Canada $904M AUM 39.64% 1-Year Est. Return
GGI
Galaxy Group Investments New York $843M AUM 47.48% 1-Year Est. Return
WFAL
Wedbush Fund Advisers, LLC Pasadena, California $967M AUM
OBWP
O'Brien Wealth Partners Waltham, Massachusetts $756M AUM 13.93% 1-Year Est. Return
TWM
Tolleson Wealth Management Dallas, Texas $693M AUM 17.6% 1-Year Est. Return
AGC
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return

Iron Triangle Partners's Q4 2023 Portfolio in Review

As of Q4 2023, Iron Triangle Partners held 33 positions worth $773M, up 13% from $684M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Iron Triangle Partners's Q4 2023 filing shows 10 new, 7 increased, 8 reduced and 7 closed positions. Its largest new stake was Idexx Laboratories: 76,025 shares worth $42.2M. The largest sale was United Therapeutics, an estimated $47.6M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Iron Triangle Partners's largest Q4 2023 buy was Idexx Laboratories: 76,025 shares worth $42.2M.
  • Iron Triangle Partners added most to Icon in Q4 2023, an estimated $11M increase.
  • Iron Triangle Partners's biggest Q4 2023 reduction was DexCom, cutting an estimated $28.2M.
  • Iron Triangle Partners fully exited United Therapeutics in Q4 2023, selling an estimated $47.6M.
  • Iron Triangle Partners's ten largest holdings make up 56% of its $773M portfolio in Q4 2023.
  • Iron Triangle Partners opened 10 new positions and closed 7 in Q4 2023.
  • Iron Triangle Partners's portfolio value rose 13% quarter-over-quarter to $773M.

Based on Iron Triangle Partners's 13F filing for Q4 2023, filed 14 Feb 2024.